Susquehanna International Group’s 89bio ETNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-651,873
| Closed | -$9.58M | – | 12670 |
|
|
2025
Q3 | $9.58M | Buy |
651,873
+322,012
| +98% | +$3.28M | ﹤0.01% | 3097 |
|
|
2025
Q2 | $3.24M | Buy |
329,861
+161,751
| +96% | +$1.34M | ﹤0.01% | 4816 |
|
|
2025
Q1 | $1.22M | Buy |
168,110
+103,931
| +162% | +$909K | ﹤0.01% | 6753 |
|
|
2024
Q4 | $502K | Sell |
64,179
-275,892
| -81% | -$2.27M | ﹤0.01% | 8653 |
|
|
2024
Q3 | $2.52M | Buy |
340,071
+30,655
| +10% | +$258K | ﹤0.01% | 4845 |
|
|
2024
Q2 | $2.48M | Buy |
309,416
+129,454
| +72% | +$1.16M | ﹤0.01% | 4670 |
|
|
2024
Q1 | $2.09M | Buy |
179,962
+13,752
| +8% | +$152K | ﹤0.01% | 5224 |
|
|
2023
Q4 | $1.86M | Sell |
166,210
-214,857
| -56% | -$1.97M | ﹤0.01% | 5525 |
|
|
2023
Q3 | $5.88M | Buy |
381,067
+133,271
| +54% | +$2.24M | ﹤0.01% | 3274 |
|
|
2023
Q2 | $4.7M | Sell |
247,796
-396,305
| -62% | -$6.96M | ﹤0.01% | 3645 |
|
|
2023
Q1 | $9.81M | Buy |
644,101
+412,851
| +179% | +$5.38M | ﹤0.01% | 2479 |
|
|
2022
Q4 | $2.94M | Buy |
+231,250
| New | +$2.08M | ﹤0.01% | 4046 |
|
|
2022
Q3 | – | Sell |
-55,519
| Closed | -$244K | – | 13417 |
|
|
2022
Q2 | $179K | Buy |
55,519
+37,153
| +202% | +$112K | ﹤0.01% | 10800 |
|
|
2022
Q1 | $69K | Buy |
+18,366
| New | +$118K | ﹤0.01% | 12138 |
|
|
2021
Q2 | – | Sell |
-14,968
| Closed | -$334K | – | 12723 |
|
|
2021
Q1 | $354K | Buy |
+14,968
| New | +$345K | ﹤0.01% | 10258 |
|
Other funds holding ETNB
Susquehanna International Group's ETNB Position: Q4 2025 in Review
Susquehanna International Group sold out of 89bio (ETNB) in Q4 2025, closing a stake of 651,873 shares — an estimated $9.58M sold.
Susquehanna International Group first reported a position in ETNB in Q1 2021 and held it in 15 quarters. The position peaked at $9.81M in Q1 2023. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.
- Susquehanna International Group reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
- Susquehanna International Group sold 651,873 89bio shares in Q4 2025, an estimated $9.58M.
- Susquehanna International Group first reported a position in 89bio in Q1 2021 and held it in 15 quarters.
- Susquehanna International Group's 89bio position peaked at $9.81M in Q1 2023.
- 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.
Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.